Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Arachnoiditis
NCT00284505Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of thalidomide in arachnoiditis, sponsored by Washington University School of Medicine. Primary endpoints: Change in pain as measured by the McGill Pain Questionnaire, short form, Consumption of adjuvant opioid medications and 1 more. Started Jul 2005; status: completed.
02
Drugs
thalidomide
03
Conditions
arachnoiditis
Beyond the preview
Go deeper on NCT00284505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284505.